Tepha
BD announced the acquisition of a developer and manufacturer of a resorbable polymer technology (poly-4-hydroxybutyrate, P4HB) to expand its bioresorbable surgical mesh portfolio and enable applications in soft tissue repair, reconstruction and regeneration. The transaction was described as providing vertical integration of a polymer supply chain component and as enabling further application of the polymer technology across medical devices.
Industries
Nr. of Employees
medium (51-250)
Patents
Medical devices containing compositions of poly(butylene succinate) and copolymers thereof
US-12151050-B2
View DetailsThree-dimensional resorbable implants for tissue reinforcement and hernia repair
US-12109100-B2
View Details
Medical devices containing compositions of poly(butylene succinate) and copolymers thereof
US-12151050-B2
View DetailsThree-dimensional resorbable implants for tissue reinforcement and hernia repair
US-12109100-B2
View DetailsProducts
Resorbable P4HB polymer platform
A resorbable poly-4-hydroxybutyrate (P4HB) polymer technology platform intended for use as a material component in implantable medical devices and scaffolds.
Bioresorbable surgical mesh and scaffold products for soft tissue support
Implantable mesh and scaffold products designed to provide short-term mechanical support for soft tissue repairs, promote tissue ingrowth, and gradually resorb.
Resorbable P4HB polymer platform
A resorbable poly-4-hydroxybutyrate (P4HB) polymer technology platform intended for use as a material component in implantable medical devices and scaffolds.
Bioresorbable surgical mesh and scaffold products for soft tissue support
Implantable mesh and scaffold products designed to provide short-term mechanical support for soft tissue repairs, promote tissue ingrowth, and gradually resorb.
Expertise Areas
- Biomaterials for soft tissue repair
- Bioresorbable polymer development and manufacturing
- Surgical mesh and implantable device manufacturing
- Supply chain integration for critical medical-grade materials
Key Technologies
- Poly-4-hydroxybutyrate (P4HB) resorbable polymer
- Bioresorbable surgical mesh and scaffold materials
- Resorbable polymer synthesis and processing
- Biomaterials engineered for tissue integration and controlled resorption
News & Updates
BD announced the acquisition of a developer and manufacturer of a proprietary resorbable poly-4-hydroxybutyrate (P4HB) polymer technology platform to expand its bioresorbable surgical mesh portfolio and enable applications in soft tissue repair and regeneration.
Described as the company's sixth tuck-in acquisition completed in fiscal 2021; transaction was reported as immaterial to BD's fiscal 2021 financial results.
BD announced the acquisition of a developer and manufacturer of a proprietary resorbable poly-4-hydroxybutyrate (P4HB) polymer technology platform to expand its bioresorbable surgical mesh portfolio and enable applications in soft tissue repair and regeneration.
Described as the company's sixth tuck-in acquisition completed in fiscal 2021; transaction was reported as immaterial to BD's fiscal 2021 financial results.